Pharmaceutical Executive
November 09, 2019
Features
39
11
Pharm Exec chronicles the journey of gene therapy visionary R. Jude Samulski, whose work unraveling the mysteries of adeno-associated virus continues to fuel new hopes in transforming drugs for rare disease.
November 09, 2019
From the Editor
39
11
Though uncertain market dynamics remain at play, the current magnitude of innovation in biopharma is staggering, and, at times, overwhelming.
November 08, 2019
Columns
39
11
Measure would cut drug costs, slash revenues, curb R&D.
November 08, 2019
Columns
39
11
A formal effort is underway in Europe to gather concrete clues on the value of real-world evidence in payer decision-making.
November 07, 2019
Columns
39
11
Technology grabbing the attention of watchful industry
November 07, 2019
Features
39
11
With pursuits of complex therapies more routine, biotech platform companies are tasked with aligning their science with process and manufacturing proficiency to stand out in an increasingly crowded investment field.
November 01, 2019
Issue PDF
39
11
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.
November 01, 2019
Special Sponsored Section
39
11
Boasting a long and proud tradition in the life sciences, consistently ranked among the world’s most pioneering countries, Sweden’s biggest task will be to maintain such standards in an era where medical science is becoming ever more sophisticated and integrated with other disciplines.